Ekso Bionics (NASDAQ:EKSO) Announces Earnings Results, Misses Expectations By $0.02 EPS

Ekso Bionics (NASDAQ:EKSO) posted its quarterly earnings results on Monday. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02), Yahoo Finance reports. Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. During the same quarter in the previous year, the company posted ($0.24) EPS.

Ekso Bionics Stock Performance

NASDAQ:EKSO opened at $1.13 on Tuesday. Ekso Bionics has a twelve month low of $0.83 and a twelve month high of $3.13. The firm has a market capitalization of $20.54 million, a price-to-earnings ratio of -1.16 and a beta of 1.45. The company has a current ratio of 2.42, a quick ratio of 1.77 and a debt-to-equity ratio of 0.36. The firm’s fifty day simple moving average is $1.11 and its 200 day simple moving average is $1.15.

Analysts Set New Price Targets

EKSO has been the topic of several research reports. StockNews.com initiated coverage on Ekso Bionics in a research report on Saturday. They issued a “hold” rating on the stock. HC Wainwright cut their price objective on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Tuesday.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.